Introduction
============

Laser in situ keratomileusis (LASIK) is the most common procedure for correction of myopia.[@b1-opth-7-591] Despite technological advancements, LASIK still has unresolved problems, such as reduced tear function and increased corneal staining (indicating ocular surface epitheliopathy).[@b2-opth-7-591],[@b3-opth-7-591] Tear function is closely related to corneal sensation, and cutting of a flap during LASIK reduces corneal sensitivity, as corneal nerves are truncated.[@b4-opth-7-591]

Femtosecond lasers have become a popular option to create corneal flaps, due to greater efficacy, predictability, and safety. The IntraLase™ femtosecond laser (Abbott Medical Optics Inc, Santa Ana, CA, USA) was the first laser introduced into the refractive surgery market. New technological developments have led to the introduction of a range of femtosecond lasers, including the VisuMax (Carl Zeiss Meditec, Jena, Germany). Newer platforms allow one to create smaller flaps, use higher repetition rates, and lower laser pulse energy as well as utilize different suction methods that may have less adverse effects on corneal nerves and tear function. The VisuMax laser, with a higher repetition rate, utilizes lower energy and corneal suction, while the IntraLase laser, with a lower repetition rate, uses higher energy and conjunctival suction.

Dry eye is the major predicament associated with LASIK.[@b5-opth-7-591] It has been demonstrated that femtosecond flaps have a lower incidence of LASIK-associated dry eye as compared with flaps created by microkeratomes.[@b6-opth-7-591] However, it is not known whether the newer femtosecond lasers have an even greater potential to better preserve tear function. Hence, this current study aimed to investigate whether the use of the VisuMax laser for flap creation was equivalent to the IntraLase laser in terms of corneal sensitivity, tear film break up time (TBUT), Schirmer's test, and corneal fluorescein staining.

Methodology
===========

Study design
------------

This study was a prospective, contralateral paired-eye, clinical trial (ClinicalTrials.gov identifier: NCT01252654) comparing corneal sensitivity, tear function, and corneal staining, following femtosecond LASIK, in myopic patients at the Singapore National Eye Centre. The study was approved by the Singapore Eye Research Institute Ethics Committee and adhered to the tenets of the Declaration of Helsinki. One of the femtosecond lasers (either VisuMax or IntraLase) was randomly assigned to the first eye, and the alternative technique was used in the contralateral eye. A full LASIK procedure was completed on the first eye before it was performed on the second eye. Procedures were performed by certified and experienced surgeons (JSM, MR, and CMLC).

Patient selection
-----------------

Forty-five consecutive patients were enrolled after written informed consent was obtained. Inclusion criteria were a stable myopia prescription for the previous 6 months, best corrected visual acuity of 20/20 or better, a spherical equivalent difference of no more than 2 diopter (D) spheres in both eyes, and a minimal corneal thickness of at least 500 μm. Patients without contact lens--related problems ceased wear of soft contact lenses for at least 2 weeks and rigid gas permeable lenses for at least 3 weeks, to obtain stable keratometry readings.

Patients were excluded if they had corneal or anterior segment pathology, retinal degeneration, keratoconus, previous ocular surgery, a history of herpes zoster ophthalmicus or herpes simplex keratitis, diabetes mellitus, autoimmune disease, severe dry eye, connective tissue disease or significant atopic syndrome, or were undergoing chronic systemic corticosteroid or immunosuppressive therapy. Patients with intraocular pressure of more than 21 mmHg or a history of a steroid-induced increase in intraocular pressure were excluded. This criteria was selected to prevent posterior segment damage, as the intraocular pressure has been shown to rise up to 82 mmHg during the suction procedure.[@b7-opth-7-591]

Preoperative and postoperative evaluation was comprised of uncorrected distance visual acuity, manifest refraction, corrected distance visual acuity, and slit lamp biomicroscopy. Additionally, preoperative evaluation included noncontact tonometry (NT-3000 Auto Non Contact Tonometer; NIDEK Co, Ltd, Aichi, Japan), pachymetry (Orbscan^®^IIz; Bausch and Lomb, Rochester, NY, USA), and fundus assessment.

Surgical technique
------------------

Corneal flaps were created with a 500 kHz VisuMax laser or a 60 kHz IntraLase laser. The mean targeted flap diameter for VisuMax was 8.4 ± 0.0 mm and for IntraLase was 8.9 ± 0.2 mm. The targeted flap thickness was 110 to 115 μm, for both techniques. The laser parameters for the VisuMax were: small (S) cone, superior hinge, side-cut angle 85 degrees, hinge angle 70 degrees, laser-bed energy 0.16 to 0.165 μJ, spot separation 1.5 μm (rim) and 4.8 μm (lamellar), and line spot separation 1.5 μm (rim) and 4.8 μm (lamellar). The laser parameters for the IntraLase were: standard suction, superior hinge, side-cut angle 70 degrees, hinge angle 50 degrees, laser-bed energy 0.95 μJ (range 0.92 to 1.08 μJ), pocket enable on, pocket width 0.25 mm, pocket start depth 230 μm, pocket tangent 7 μm, and radian spot separation 6 μm.

Stromal tissue laser ablation was performed with the WaveLight^®^ Allegretto Eye-Q 400 Hz excimer laser system (Alcon Laboratories Inc, Fort Worth, TX, USA), using the wavefront-optimized treatment profile. The attempted optical zone was 6.50 mm, and the target refraction was plano spherical equivalent.

All eyes were treated with nonpreserved moxifloxacin hydrochloride 0.5% eye drops (Vigamox^®^, Alcon Laboratories Inc) and dexamethasone 0.1% eye drops (Maxidex™, Alcon Laboratories Inc), four times daily for 1 week. Nonpreserved artificial tears (Tears Naturale Free^®^, Alcon Laboratories Inc) were prescribed postoperatively as follows: hourly for the first 7 days, eight times daily for 1 week, five times daily for 1 month, and then four times daily for the remaining period of the study. However, if this regimen was not sufficient, the dosage was adjusted to the patient's symptoms.

Postoperative follow-up visits were at 1 day, 1 week, 1 month, and 3 months. All examiners evaluating patients postoperatively were masked.

Clinical outcome measures
-------------------------

The outcome measures were comprised of corneal sensitivity, TBUT, Schirmer's test, and corneal fluorescein staining. Measurements for corneal sensitivity were taken preoperatively at 1 month and at 3 months postoperatively, while other outcome measures were collected at each visit, except at 1 day postoperatively. TBUT and corneal staining were evaluated after instillation of fluorescein. TBUT was defined as the time taken (in sec) for the first dark spot to appear on the cornea from the moment of eye opening. The cornea was assessed using fluorescein dye and divided into three horizontal zones (upper, middle, and lower). Positive staining scores were: 0 (no staining), 1 (some staining), 2 (staining in more than half of the area), and 3 (staining in the whole zone). Staining scores were added from each zone, for a total staining score ranging from 0 to 9. Corneal sensitivity was measured in five zones, using the Cochet-Bonnet esthesiometer (Visionix Luneau, Paris, France). The patient was positioned on an ophthalmic chin and brow rest of a slit lamp, and a nylon monofilament of 6.00 cm was perpendicularly advanced to the central cornea. The filament was shortened in 0.50 cm increments, if the patient did not feel the filament. Measurements (in cm) were repeated in the superior, inferior, temporal, and nasal zones. The reduction of corneal sensitivity was equal in all zones, and the average values were reported. Tear production was tested by Schirmer's tests (Sno strips^®^, Bausch and Lomb), without anesthesia, and the length of wetting (in mm) within 5 minutes was recorded.

Statistics
----------

Sample size calculations were based on the efficacy of myopic correction.[@b8-opth-7-591] To achieve 80% power at alpha of 5%, using a noninferiority limit of 92% and assuming success rate of 75%, a sample size of 41 patients was required in each group to show noninferiority. As this trial was designed to be a contralateral paired-eye study, a total of 45 patients were recruited to allow for withdrawal.

A paired *t*-test was used to compare the preoperative parameters, ie, spherical equivalent and keratometry. The differences in clinical outcomes over time and between femtosecond platforms at various visits were analyzed with a mixed linear model, using the SPSS package (Version 17.0, IBM, Armonk, NY, USA). The dependent variables were corneal sensitivity, TBUT, Schirmer's test, and corneal staining, while fixed factors included visit, femtosecond laser, and level of myopia. The levels of myopia were defined as low myopia (\<−6.00 D) and high myopia (≥−6.00 D). The operating surgeon, patient age, and patient gender were included as covariates, to model their influence on each dependent variable. Pearson's correlations were performed, to identify significant interactions between refractive status and clinical measures. A significance level (alpha) of 0.05 was used.

Results
=======

Demographics
------------

[Table 1](#t1-opth-7-591){ref-type="table"} shows patient data and preoperative ocular parameters. The study enrolled 45 patients, with a mean age of 28.8 years old (range 21 to 39 years), and 56% were females. The preoperative spherical equivalent for all eyes, expressed as mean ± standard deviation, was −4.93 ± 2.09 D (range 11.25 to −1.375 D), and keratometry was 44.09 ± 1.70 D (range 40.20 to 48.80 D). Forty-five patients were followed up for 1 month and 39 patients for 3 months.

Refractive outcomes
-------------------

There was no difference in visual acuity between VisuMax- or IntraLase-treated eyes. The uncorrected distance visual acuity was significantly improved in both platforms (*P* \< 0.001).

Clinical outcome measures
-------------------------

Corneal sensitivity following LASIK was not statistically different when both femtosecond platforms were compared (*P* = 0.90). However, corneal sensitivity was dependent on preoperative levels of myopia (*P* \< 0.001). The data was split into high and relatively low myopia. A trend towards slightly greater reduction was observed in IntraLase-operated eyes, with myopia less than −6.00 D at the 1 month postoperative visit (*P* \> 0.05) ([Table 2](#t2-opth-7-591){ref-type="table"}). Over time, corneal sensitivity was generally decreased for both techniques at 1 week (*P* \< 0.04), 1 month (*P* \< 0.001), and 3 months (*P* \< 0.001) after surgery.

The TBUT and Schirmer's values were significantly reduced at 1 week (*P* \< 0.05), but there was no difference between the two femtosecond lasers at any visit (*P* \> 0.05) ([Tables 3](#t3-opth-7-591){ref-type="table"} and [4](#t4-opth-7-591){ref-type="table"}). Due to a low number of eyes, a statistical comparison for TBUT based on myopia could only be performed in eyes with myopia less than −6.00 D. A consistent, but not significant, tendency for lower TBUT values was observed with the IntraLase (*P* \> 0.05) ([Table 4](#t4-opth-7-591){ref-type="table"}).

Although there was a general and significant increase in corneal staining after LASIK (*P* \< 0.05), the staining between both femtosecond lasers was not statistically different at any visit (*P* = 0.70) ([Table 5](#t5-opth-7-591){ref-type="table"}).

Discussion
==========

This current study investigated, for the first time, whether newer femtosecond lasers have a greater potential to better preserve tear function. We assessed the effect of VisuMax- and IntraLase-created flaps on corneal sensitivity, tear function, and corneal health in myopic patients over a 3-month period. The present study focused on clinical parameters, and detailed refractive outcomes were published elsewhere.[@b9-opth-7-591]

This report showed that both platforms were not statistically different in terms of clinical outcomes. However, a trend towards greater reduction of corneal sensitivity and TBUT was observed in IntraLase-treated eyes.

Overall, a significant reduction in corneal sensitivity following LASIK persisted for up to 3 months postoperatively, with a larger decrease noted in high myopic eyes. Furthermore, significantly diminished Schirmer's and TBUT values as well as increased corneal staining were recorded for up to 1 week postoperatively.

Corneal sensitivity
-------------------

It is generally accepted that thick LASIK corneal flaps cause greater damage to corneal nerves than thinner flaps.[@b5-opth-7-591],[@b10-opth-7-591] In recent years, surgeons aimed to create thinner flaps, of around 100 μm, to minimize corneal nerve damage and reduce the incidence of LASIK-induced dry eye. Naturally, the process of photoablation to correct the desired amount of myopia plays an important role, ie, a higher target correction of myopia requires deeper ablation, thereby damaging more corneal nerves.[@b11-opth-7-591] In the current 3-month study, corneal sensitivity did not return to preoperative levels, which concurs with previous investigations that have demonstrated that nerve recovery may take as long as 6 months or even longer.[@b10-opth-7-591],[@b12-opth-7-591]

The current study highlighted that a higher level of myopia, corresponding to greater ablation depth, negatively affected corneal sensitivity, which is in agreement with findings of previous studies.[@b11-opth-7-591],[@b13-opth-7-591] A detailed analysis in this present study showed that a higher amount of necessary correction reduced corneal sensitivity by up to 44%, while a lower amount of correction diminished sensitivity by about 17%. It has been suggested that larger flap diameters may reduce sensitivity to a higher degree as a result of greater corneal nerve insult.[@b11-opth-7-591] A slightly greater, but not significant, loss of corneal sensitivity was noted in relatively low myopic IntraLase-treated eyes at 1 month postoperatively, which may have been derived from the larger flap size. The reason for this insignificant finding may be that the difference in flap diameter of 0.5 mm between both techniques was too small or that the sample size was not sufficient to show a significant effect. However, a similar finding was made in a study that compared eyes with femtosecond laser--or microkeratome-created flaps.[@b12-opth-7-591] In that study, the diameter of the microkeratome flaps was generally 0.4 mm larger. The study could not show differences in subbasal nerve density or corneal sensitivity between the larger microkeratome and the smaller femtosecond laser flaps.[@b12-opth-7-591]

Loss of corneal sensitivity and subsequent LASIK-induced dry eye has been mainly attributed to the LASIK flap. A way of reducing damage to corneal nerves may be to avoid cutting a flap altogether. A recently introduced modification of femtosecond lenticule extraction (FLEx), named small incision lenticule extraction (SMILE),[@b14-opth-7-591] cuts a refractive lenticule that is manually removed from the cornea through a small incision. Such an alternative keeps most corneal nerves intact and has the potential to significantly improve dry eye symptoms.

TBUT and Schirmer's test
------------------------

Truncation of corneal nerves during flap creation interrupts the neuronal feedback mechanism linking the lacrimal gland and cornea. As a consequence of corneal denervation, a reduction in tear secretion and dry eye symptoms may occur.[@b15-opth-7-591],[@b16-opth-7-591] Most studies have confirmed this hypothesis and have reported diminished Schirmer's values for up to 1 week[@b17-opth-7-591],[@b18-opth-7-591] or even 6 months postoperatively.[@b2-opth-7-591],[@b19-opth-7-591]--[@b21-opth-7-591]

The present study did not identify differences between the two femtosecond platforms, but found Schirmer's values that were generally lower 1 week following LASIK as compared with preoperative values. In contrast, some studies found little or no changes in Schirmer's values.[@b3-opth-7-591],[@b16-opth-7-591],[@b22-opth-7-591] The reason for this short-term decline in tear secretion is not clear. We observed a decrease in corneal sensitivity for up to 3 months postoperatively, which implies corneal denervation. It may be possible that peripheral and unaffected nerves compensated for the loss of some of the corneal sensation, thereby partially restoring function of the neuronal feedback loop and facilitating lubrication of the ocular surface.

Previous literature is inconsistent in regards to tear film stability following LASIK. It has been reported that TBUT was diminished in both microkeratome- and femtosecond laser--created flaps.[@b2-opth-7-591],[@b5-opth-7-591],[@b11-opth-7-591],[@b20-opth-7-591],[@b21-opth-7-591],[@b23-opth-7-591] Some authors found no significant changes in TBUT,[@b16-opth-7-591],[@b22-opth-7-591] while others noted a slight, but insignificant, increase in TBUT, in particular when using femtosecond lasers.[@b17-opth-7-591],[@b24-opth-7-591]

The present findings showed that TBUT was significantly reduced 1 week after surgery. In relative contrast to earlier reports that noticed an increased TBUT, we detected TBUT values that appeared to be slightly, but not significantly, lower in the IntraLase-treated eyes as compared with VisuMax. This finding may be explained by the different suction mechanisms used in both platforms. While the IntraLase system applies suction onto the sclera via a suction ring, the VisuMax system creates suction on the cornea via a curved contact glass. The high level of pressure induced by a suction ring onto the sclera has been shown to reduce the number of goblet cells in the bulbar conjunctiva.[@b25-opth-7-591] The tear film stability may therefore directly be affected by a compromised mucin layer, hence resulting in a slightly less stable tear film, as shown in the IntraLase-treated eyes of the current study.

Corneal staining
----------------

Greater levels of corneal staining may be expected following LASIK, as a result of loss in corneal sensation and subsequent reduced tear secretion as well as increased tear osmolarity.[@b19-opth-7-591],[@b26-opth-7-591] This idea concurs with previous reports.[@b3-opth-7-591],[@b5-opth-7-591],[@b16-opth-7-591],[@b22-opth-7-591],[@b23-opth-7-591] In the present study, corneal staining was elevated at 1 week postoperatively and returned to baseline levels after 1 month.[@b5-opth-7-591],[@b22-opth-7-591] This appears to be in line with current findings, with the exception that corneal staining levels did not return to extremely low preoperative baseline levels. Some studies reported persistent corneal staining for up to 6 months, which may not be explained by a decrease in tear secretion. Specifically, Wilson[@b3-opth-7-591] observed Rose Bengal staining patterns developing 1 to 3 months postoperatively that disappeared 6 months postoperatively, coinciding with the return of corneal sensation.[@b27-opth-7-591],[@b28-opth-7-591] Furthermore, Wilson reported no changes in tear secretion, indicating that staining was not a result of decreased tear production.[@b3-opth-7-591] He suggested that punctate epithelial erosions after surgery may be attributed to neurotrophic epitheliopathy.

Comparison of lasers
--------------------

Generally, we did not identify significant differences in corneal sensation, tear stability, or corneal health, between VisuMax and IntraLase. One may have hypothesized that technical specifications, such as a nonapplanating docking surface, shorter pulse duration, higher repetition rate, and reduced laser pulse energy as well as the smaller flap size of VisuMax, may influence clinical outcome measures to a lesser extent as compared with IntraLase.[@b29-opth-7-591],[@b30-opth-7-591] The present study indicated that despite their technical differences, both platforms have relatively similar effects on the ocular surface.

There were a few limitations of the study. This present study was powered for refractive error outcomes, and the sample size may have been too low to show a statistical difference in clinical outcomes between the femtosecond laser platforms. Therefore, this study serves as a pilot study to appropriately calculate sample sizes for future studies.

The current study utilized 50-degree and 70-degree hinge angles for the VisuMax and IntraLase flaps, respectively. In our experience, optimal results for each platform have been achieved with the specified hinge angles. A different study tested the effect of 45-degree or 90-degree hinge angles on corneal sensitivity in femtosecond laser flaps, over a 12-month follow up period.[@b5-opth-7-591],[@b22-opth-7-591] The authors concluded that overall, hinge position and hinge angles had no effect on corneal sensation and dry eye sensations.[@b5-opth-7-591],[@b22-opth-7-591] In the current study, however, VisuMax and IntraLase hinge angles differed by 20 degrees, an amount that is a lot smaller than the 45-degree difference employed by the previous study.[@b5-opth-7-591]

Conclusion
==========

In summary, the present study found that the VisuMax and IntraLase femtosecond lasers did not affect the ocular surface system in a significantly different manner. We noted an ablation depth-dependent reduction in corneal sensitivity that persisted up to 3 months after surgery as well as diminished tear secretion and increased corneal staining at 1 week postoperatively. These findings suggest that the choice of a suitable femtosecond laser for a patient may be based on the surgeon's preference rather than any differential potential to cause dry eyes. However, a trend towards slightly lower reductions in corneal sensitivity and TBUT were observed in the VisuMax-operated eyes, which may be attributed to improved technical specifications.
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###### 

Patient data and preoperative ocular parameters

  Flap creation   Mean age, range (years)   Sex (n)   Eyes (n)   Mean SER ± SD (D)   Mean K ± SD (D)   
  --------------- ------------------------- --------- ---------- ------------------- ----------------- --------------
  VisuMax         28.8, 21--39              20        25         45                  −4.94 ± 2.08      44.16 ± 1.81
  IntraLase™                                                     45                  −4.91 ± 2.09      44.02 ± 1.61
  *P-*value       --                        --        --         --                  0.94              0.26

**Notes:** VisuMax (Carl Zeiss Meditec, Jena, Germany) and IntraLase™ (Abbott Medical Optics Inc, Santa Ana, CA, USA).

**Abbreviations:** SER, spherical equivalent refraction; SD, standard deviation; K, keratometry; D, diopter.

###### 

Changes over time in corneal sensitivity following VisuMax or IntraLase™ LASIK

  Preop       1 month     3 months                                                                                   
  ----------- ----------- ---------- ----- ----- ------- ----- ----- ----- ------- ------- ----- ----- ----- ------- -------
  ≥−6.00 D    VisuMax     5.9        4.9   6.9   0.434   3.5   2.4   4.6   −40.7   0.335   4.0   2.8   5.1   −32.3   0.468
              IntraLase   5.7        4.5   7.0           3.8   2.4   5.1   −34.3           3.2   1.8   4.6   −43.6   
              Eyes (n)    24                             21                                18                        
  \<−6.00 D   VisuMax     5.9        5.5   6.3   0.086   5.3   4.9   5.8   −9.7    0.095   5.2   4.7   5.6   −12.5   0.107
              IntraLase   5.8        5.3   6.3           4.8   4.3   5.3   −17.1           4.9   4.4   5.4   −14.8   
              Eyes (n)    63                             55                                54                        

**Notes:** Estimated mean of corneal sensitivity, lower and upper bound of 95% confidence interval. VisuMax (Carl Zeiss Meditec, Jena, Germany) and IntraLase™ (Abbott Medical Optics Inc, Santa Ana, CA, USA).

**Abbreviations:** LASIK, laser in situ keratomileusis; CI, confidence interval.

###### 

Reduction of TBUT following VisuMax and IntraLase™ LASIK

  Preop       1 week      1 month   3 months                                                                                                                    
  ----------- ----------- --------- ---------- ------ ------- ----- ----- ------ ------- ------- ----- ----- ------ ------- ------- ------ ----- ------ ------- -------
  ≥−6.00 D    VisuMax     10.1      8.8        11.4   0.318   8.3   5.8   10.9   −17.4   --      8.6   6.9   10.3   −14.8   --      10.2   8.6   11.9   +1.4    --
              IntraLase   9.5       7.9        11.1           5.3   2.3   8.3    −44.1           7.5   5.6   9.4    −20.8           8.2    5.9   10.4   −14.2   
              Eyes (n)    25                                  5                                  13                                 13                          
  \<−6.00 D   VisuMax     10.5      9.1        11.9   0.377   8.8   6.5   11.0   −16.6   0.211   9.3   7.5   11.1   −11.6   0.981   8.8    7.0   10.6   −16.8   0.892
              IntraLase   10.2      8.9        11.4           7.5   5.9   9.2    −25.9           8.4   6.9   9.8    −17.7           8.0    6.6   9.5    −21.0   
              Eyes (n)    62                                  19                                 33                                 36                          

**Notes:** Estimated mean of TBUT, lower and upper bound of 95% confidence interval. A statistical comparison using the linear mixed model adjusted for surgeon, age, and gender could not be performed for a level of myopia greater than −6.00 D due to small sample size.

**Abbreviations:** TBUT, tear film break up time; LASIK, laser in situ keratomileusis; CI, confidence interval; D, diopter.

###### 

Reduction of Schirmer's value following VisuMax and IntraLase™ LASIK

  Preop       1 week      1 month   3 months                                                                                                                       
  ----------- ----------- --------- ---------- ------ ------- ------ ----- ------ ------- ------- ------ ----- ------ ------- ------- ------ ------ ------ ------- -------
  ≥−6.00 D    VisuMax     11.3      7.6        15.0   0.577   8.8    5.1   12.5   −22.1   0.542   10.4   6.6   14.2   −7.8    0.464   10.1   6.1    14.1   −10.5   0.447
              IntraLase   11.7      6.6        16.9           9.2    3.9   14.5   −21.6           12.4   7.1   17.7   +5.8            9.4    3.9    14.8   −20.2   
              Eyes (n)    24                                  22                                  21                                  18                           
  \<−6.00 D   VisuMax     15.2      12.2       18.3   0.316   12.4   9.4   15.3   −18.8   0.233   12.8   9.7   15.9   −16.0   0.956   12.7   9.5    15.9   −16.3   0.069
              IntraLase   13.7      11.0       16.4           10.7   8.0   13.4   −21.9           12.4   9.7   15.2   −9.0            13.7   10.9   16.6   +0.4    
              Eyes (n)    62                                  62                                  57                                  51                           

**Notes:** Estimated mean of Schirmer's, lower and upper bound of 95% confidence interval. VisuMax (Carl Zeiss Meditec, Jena, Germany) and IntraLase™ (Abbott Medical Optics Inc, Santa Ana, CA, USA).

**Abbreviations:** LASIK, laser in situ keratomileusis; CI, confidence interval; D, diopter.

###### 

Changes over time in corneal fluorescein staining and incidence rates following VisuMax or IntraLase™ LASIK

  Preop       1 week      1 month   3 months                                                           
  ----------- ----------- --------- ---------- ----- ----- ----- ------ ----- ----- ------ ----- ----- ------
  ≥−6.00 D    VisuMax     0.0       0.0        0     0.5   0.3   38.5   0.4   0.2   30.8   0.3   0.2   18.2
              IntraLase   0.1       0.1        8.3   0.6   0.3   16.7   0.3   0.2   25.0   0.2   0.2   20.0
              Eyes (n)    25                         25                 25                 21          
  \<−6.00 D   VisuMax     0.0       0.0        3.2   0.7   0.2   35.5   0.1   0.1   6.5    0.2   0.1   21.4
              IntraLase   0.0       0.0        0     0.9   0.2   46.9   0.2   0.1   15.6   0.3   0.1   13.8
              Eyes (n)    65                         65                 65                 57          

**Notes:** Estimated mean of corneal staining score ± standard error. VisuMax (Carl Zeiss Meditec, Jena, Germany) and IntraLase™ (Abbott Medical Optics Inc, Santa Ana, CA, USA).

**Abbreviations:** LASIK, laser in situ keratomileusis; SE, standard error; D, diopter.
